Directory
>
Karen Joyce
Karen Joyce
Executive Director, Regulatory Affairs | Cara Therapeutics
Boston, Massachusetts, United States
Karen Joyce
Summary
Karen Joyce is an accomplished Executive Director specializing in Regulatory Affairs within the biotechnology sector, with a robust track record in driving clinical development and regulatory submissions. Her extensive experience spans over three decades, showcasing her expertise in clinical trials, drug development, and navigating complex regulatory landscapes. Karen has held senior roles at leading organizations, including Cara Therapeutics and Novartis Pharmaceuticals, demonstrating her capability to lead teams and influence strategic decisions. Her unique blend of technical knowledge and leadership acumen positions her as a key player in the pharmaceutical industry. Karen is passionate about ensuring that innovative therapies reach patients efficiently and safely. Outside of her professional life, she is likely to engage in continuous learning and networking within the industry, reflecting her commitment to staying at the forefront of regulatory affairs. She is based in Boston, Massachusetts, a hub for biotech innovation, which complements her career trajectory.
Karen Joyce
Work Experience
Executive Director, Regulatory Affairs at
Cara Therapeutics
October 2022 - Present
Senior Director, Regulatory Strategy at
Angion Biomedica Corp.
May 2020 - August 2022
Regulatory Affairs Consultant at
Orchard Therapeutics - U.S.
July 2019 - May 2020
Senior Regulatory Consultant at
Sage Therapeutics
May 2017 - July 2019
Senior Director, Global Regulatory Affairs at
Akebia Therapeutics
July 2015 - April 2017
Director at
Sunovion Pharmaceuticals
December 2001 - July 2015
Senior Manager, Regulatory Affairs at
NOVARTIS PHARMACEUTICALS (HK) LIMITED
January 1990 - January 1998
Karen Joyce
Education
University of Rhode Island
Frequently Asked Questions about Karen Joyce
What is Karen Joyce email address?
Karen Joyce's primary email address is ******@caratherapeutics.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Karen Joyce work for?
Karen Joyce is a Executive Director, Regulatory Affairs at Cara Therapeutics, a company specializing in Commercial physical research.
Where Karen Joyce graduated from?
Karen Joyce holds a degree in from University of Rhode Island.
How can I directly contact Karen Joyce?
To contact Karen Joyce directly, you can use the email address ******@caratherapeutics.com. Complete contact information is available upon registration with Muraena.
Who is Karen Joyce?
Karen Joyce is an accomplished Executive Director specializing in Regulatory Affairs within the biotechnology sector, with a robust track record in driving clinical development and regulatory submissions. Her extensive experience spans over three decades, showcasing her expertise in clinical trials, drug development, and navigating complex regulatory landscapes. Karen has held senior roles at leading organizations, including Cara Therapeutics and Novartis Pharmaceuticals, demonstrating her capability to lead teams and influence strategic decisions. Her unique blend of technical knowledge and leadership acumen positions her as a key player in the pharmaceutical industry. Karen is passionate about ensuring that innovative therapies reach patients efficiently and safely. Outside of her professional life, she is likely to engage in continuous learning and networking within the industry, reflecting her commitment to staying at the forefront of regulatory affairs. She is based in Boston, Massachusetts, a hub for biotech innovation, which complements her career trajectory.
Karen`s contact details
******@caratherapeutics.com
******@angion.com
***********@keryx.com
***********@sunovion.com
Colleagues
Chief Financial Officer
Executive Director, HR
Vice President, Head of Accounting and Controller
Chief Executive Officer
General Counsel, Secretary and Chief Compliance Officer
Sr Vice President Regulatory Affairs and Quality Assurance
President &CEO
Executive Director, Information Technology
President and CEO